Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Pariser

Showing results (31-40 of 115) with videos related to

Pageof 12
Sort By:
Pediatric Dermatology|November 17, 2011
Light microscopic hair shaft analysis in ectodermal dysplasia syndromesStefanie A Hirano, Ashley R Mason, Kimberly Salkey, et al.
Journal of the American Academy of Dermatology|August 23, 2012
An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: a case seriesJoan Paul, Clare E Foss, Stefanie A Hirano, et al.
Clinical Pharmacokinetics|January 12, 2021
Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary HyperhidrosisDavid M Pariser, Edward L Lain, Richard D Mamelok, et al.
Journal of the American Academy of Dermatology|February 3, 2020
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trialDavid M Pariser, Jerry Bagel, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|October 19, 2007
Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgarisDavid M Pariser, Patricia Westmoreland, Amy Morris, et al.
American Journal of Clinical Dermatology|November 1, 2018
Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled TrialsDavid M Pariser, Adelaide A Hebert, Janice Drew, et al.
Journal of Drugs in Dermatology : JDD|October 27, 2018
Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and OlderStephen K Tyring, Leon H Kircik, David M Pariser, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 24, 2016
Prevalence of Multifocal Primary Hyperhidrosis and Symptom Severity Over Time: Results of a Targeted SurveyDee Anna Glaser, Angela M Ballard, Niquette L Hunt, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 31, 2024
A Pivotal Study on the Safety and Effectiveness of a Targeted Alkali Thermolysis Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary SweatingStacy Smith, Dee Anna Glaser, Lawerence J Green, et al.
Journal of Drugs in Dermatology : JDD|July 14, 2018
Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of TherapyDavid M Pariser, Lawrence J Green, Linda Stein Gold, et al.
Pageof 12

Showing results (31-40 of 115) with videos related to

Sort By:
Pageof 12
Pediatric Dermatology|November 17, 2011
Light microscopic hair shaft analysis in ectodermal dysplasia syndromesStefanie A Hirano, Ashley R Mason, Kimberly Salkey, et al.
Journal of the American Academy of Dermatology|August 23, 2012
An open-label pilot study of apremilast for the treatment of moderate to severe lichen planus: a case seriesJoan Paul, Clare E Foss, Stefanie A Hirano, et al.
Clinical Pharmacokinetics|January 12, 2021
Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary HyperhidrosisDavid M Pariser, Edward L Lain, Richard D Mamelok, et al.
Journal of the American Academy of Dermatology|February 3, 2020
Serlopitant for psoriatic pruritus: A phase 2 randomized, double-blind, placebo-controlled clinical trialDavid M Pariser, Jerry Bagel, Mark Lebwohl, et al.
Journal of Drugs in Dermatology : JDD|October 19, 2007
Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgarisDavid M Pariser, Patricia Westmoreland, Amy Morris, et al.
American Journal of Clinical Dermatology|November 1, 2018
Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled TrialsDavid M Pariser, Adelaide A Hebert, Janice Drew, et al.
Journal of Drugs in Dermatology : JDD|October 27, 2018
Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Assessment of Efficacy and Safety in Patients Aged 9 Years and OlderStephen K Tyring, Leon H Kircik, David M Pariser, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 24, 2016
Prevalence of Multifocal Primary Hyperhidrosis and Symptom Severity Over Time: Results of a Targeted SurveyDee Anna Glaser, Angela M Ballard, Niquette L Hunt, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 31, 2024
A Pivotal Study on the Safety and Effectiveness of a Targeted Alkali Thermolysis Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary SweatingStacy Smith, Dee Anna Glaser, Lawerence J Green, et al.
Journal of Drugs in Dermatology : JDD|July 14, 2018
Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of TherapyDavid M Pariser, Lawrence J Green, Linda Stein Gold, et al.
Pageof 12